Latest News 04/2012
Manipulating the immune system to develop ‘next-gen’ vaccines
The discovery of how a vital immune cell recognises dead and damaged body cells could modernise vaccine technology by ‘tricking’ cells into launching an immune response, leading to next-generation vaccines that are more specific, more effective and have fewer side-effects.
Scientists from the...
Five awarded by biochemistry and molecular biology society
Walter and Eliza Hall Institute researchers have received five of the 11 awards for excellence in biochemistry and microbiology announced by the Australian Society of Biochemistry and Molecular Biology (ASBMB) this month.
The ASBMB’s highest award, the Lemberg Medal, will be presented to institute...
Rare immune cells could hold key to treating immune disorders
The characterisation of a rare immune cell’s involvement in antibody production and ability to ‘remember’ infectious agents could help to improve vaccination and lead to new treatments for immune disorders, say researchers from the Walter and Eliza Hall Institute.
The cells, called T follicular...
Navigation
News Archives
| April 2012 | ||||||
|---|---|---|---|---|---|---|
| S | M | T | W | T | F | S |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 1 | 2 | 3 | 4 | 5 |




